These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 4601937

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multiplication of myxoviruses.
    Rott R, Scholtissek C.
    Mod Trends Med Virol; 1967; 1(0):25-48. PubMed ID: 4950641
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The proteins of Newcastle disease virus. 2. Virus-induced proteins.
    Alexander DJ, Reeve P.
    Microbios; 1972; 5(20):247-57. PubMed ID: 4673678
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The proteins of Newcastle disease virus. 1. Structural proteins.
    Alexander DJ, Reeve P.
    Microbios; 1972; 5(19):199-212. PubMed ID: 4677573
    [No Abstract] [Full Text] [Related]

  • 13. Specific requirement of serine for the growth of Newcastle disease virus.
    Ito Y, Okazaki H, Sakuma S, Homma M, Ishida N.
    Virology; 1969 Oct; 39(2):277-85. PubMed ID: 4310110
    [No Abstract] [Full Text] [Related]

  • 14. Studies on the assembly of Newcastle disease virus: incorporation of structural proteins into virus particles.
    Iinuma M, Nagai Y, Maeno K, Yoshida T, Matsumoto T.
    J Gen Virol; 1971 Sep; 12(3):239-47. PubMed ID: 5165852
    [No Abstract] [Full Text] [Related]

  • 15. Studies on the cytopathic effects of Newcastle disease virus: RNA synthesis in infected cells.
    Alexander DJ, Reeve P, Poste G.
    J Gen Virol; 1973 Mar; 18(3):369-73. PubMed ID: 4735249
    [No Abstract] [Full Text] [Related]

  • 16. Modification of Newcastle disease virus release and cytopathogenicity in cells treated with plant lectins.
    Poste G, Alexander DJ, Reeve P, Hewlett G.
    J Gen Virol; 1974 Jun; 23(3):255-70. PubMed ID: 4836906
    [No Abstract] [Full Text] [Related]

  • 17. Disappearance of neuraminidase and hemagglutinin activities in NDV-infected chick embryo cell monolayer culture treated with inhibitors of protein synthesis. Brief report.
    Lipkind MA, Tsvetkova IV.
    Arch Gesamte Virusforsch; 1971 Jun; 35(2):303-7. PubMed ID: 5167620
    [No Abstract] [Full Text] [Related]

  • 18. [Use of KB cells in the diagnosis of Newcastle's disease and titration of the virus].
    Ramisse J, Serres H, Rakotondramary E.
    Rev Elev Med Vet Pays Trop; 1969 Jun; 22(4):443-52. PubMed ID: 4926337
    [No Abstract] [Full Text] [Related]

  • 19. [Analysis of the multiplication mechanism of Newcastle disease virus (NDV), using different inhibitors].
    Schäfer W, Pister L, Schneider R.
    Z Naturforsch B; 1967 Dec; 22(12):1319-30. PubMed ID: 4384727
    [No Abstract] [Full Text] [Related]

  • 20. Genetic stability of Newcastle disease virus CG179: a strain containing only clear plaque subpopulations.
    McMillan BC, Hanson RP.
    Avian Dis; 1983 Dec; 27(3):787-91. PubMed ID: 6639553
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.